Clinical Trials Update: Sept. 9, 2004
Colorectal Cancer Breast Cancer Psychosis
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication to treat colorectal cancer. Volunteers 18 or older who have metastatic colorectal cancer (colon cancer that has spread to other organs) with radiographic evidence of disease progression during or following chemotherapy may be eligible. Research site located in Bronx, NY.
A research study of an investigational medication for the treatment of breast cancer. Post-menopausal women with advanced breast cancer whose last cancer therapy was a non-steroidal aromatase inhibitor (Arimidex or Letrozole) may be eligible. Research sites located throughout the United States.
A research study to demonstrate that an investigational drug is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. Volunteers with a clinical diagnosis of idiopathic Parkinson's disease who also exhibit symptoms of psychosis, defined by the presence of visual and/or auditory hallucinations, with or without delusions, of at least four weeks duration, may be eligible. Research site located in Pawtucket, RI.
Copyright 2004 CenterWatch. All rights reserved.